Pfizer Extends Icagen Offer Again-Pfizer recently extended the expiration date of its tender offer for all outstanding shares of Icagen, Inc.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Extends Icagen Offer Again
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account